Malakoff, France

Joffrey De Larichaudy

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 1.3

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joffrey De Larichaudy: Innovator in Cryopreservation Technology

Introduction

Joffrey De Larichaudy is a notable inventor based in Malakoff, France. He has made significant contributions to the field of cryopreservation, particularly in therapeutic applications. With a total of 2 patents to his name, his work focuses on improving methods for preserving cells for medical purposes.

Latest Patents

One of Joffrey's latest patents is a method for the cryopreservation of cells for therapeutic purposes. This invention involves a composition that includes a physiologically acceptable medium with a pH between 7.0 and 8.5, preferably between 7.0 and 8.3. The method consists of mixing the sample of cells with specific ingredients to create a suitable composition, followed by freezing the mixture. Another patent he holds also pertains to cryopreservation, detailing a composition that includes human albumin, a saccharide, DMSO, L-cysteine or coenzyme Q10, and cells for therapeutic purposes, excluding specific tumor-infiltrating lymphocytes.

Career Highlights

Throughout his career, Joffrey has worked with reputable organizations such as Laboratoire Français du Fractionnement et des Biotechnologies and Chu Nantes. His experience in these institutions has allowed him to refine his expertise in biotechnology and therapeutic applications.

Collaborations

Joffrey has collaborated with various professionals in his field, including his coworker Sandy Cazalon Nemorin. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Joffrey De Larichaudy stands out as an influential inventor in the realm of cryopreservation technology. His innovative methods and compositions are paving the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…